Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152209 | SCV000200972 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Gly23902Gly in Exon 275 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence. It has been identified in 1/2974 African Amer ican chromosomes from a broad population by the NHLBI Exome Sequencing Project ( http://evs.gs.washington.edu/EVS; dbSNP rs140942979). |
Eurofins Ntd Llc |
RCV000152209 | SCV000228577 | likely benign | not specified | 2015-02-23 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000152209 | SCV000249280 | uncertain significance | not specified | 2015-05-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000464687 | SCV000555421 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152209 | SCV001519416 | likely benign | not specified | 2021-03-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528773 | SCV001866071 | likely benign | not provided | 2020-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336300 | SCV002642033 | likely benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001528773 | SCV004042097 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Diagnostic Laboratory, |
RCV001528773 | SCV001741102 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528773 | SCV001972676 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528773 | SCV001977934 | likely benign | not provided | no assertion criteria provided | clinical testing |